UBS Group
IACB.WS

UBS Group’s ION Acquisition Corp 2 Ltd. Warrants, each whole warrant exercisable for one Class A ordinary share IACB.WS Stock Holding History

UBS Group’s Portfolio IACB.WS Stock Details IACB.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,420
Closed -$2K – 11317
2021
Q3 		$2K Buy
1,420
+1,228
+640% +$1.64K ﹤0.01% 9111
2021
Q2 		$0 Buy
+192
New +$263 ﹤0.01% 10224

Other funds holding IACB.WS

NC
Noked Capital Tel Aviv, Israel $946K AUM 17.1% 1-Year Est. Return
NI
Noked Israel Ramat Hasharon, Israel $677M AUM 69.37% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group's IACB.WS Position: Q4 2021 in Review

UBS Group sold out of ION Acquisition Corp 2 Ltd. Warrants, each whole warrant exercisable for one Class A ordinary share (IACB.WS) in Q4 2021, closing a stake of 1,420 shares — an estimated $2K sold.

UBS Group first reported a position in IACB.WS in Q2 2021 and held it in 2 quarters. The position peaked at $2K in Q3 2021. 3 funds tracked by Wall St. Rank hold IACB.WS as of Q4 2021.

  • UBS Group reported no remaining ION Acquisition Corp 2 Ltd. Warrants, each whole warrant exercisable for one Class A ordinary share position as of Q4 2021 after selling out during the quarter.
  • UBS Group sold 1,420 ION Acquisition Corp 2 Ltd. Warrants, each whole warrant exercisable for one Class A ordinary share shares in Q4 2021, an estimated $2K.
  • UBS Group first reported a position in ION Acquisition Corp 2 Ltd. Warrants, each whole warrant exercisable for one Class A ordinary share in Q2 2021 and held it in 2 quarters.
  • UBS Group's ION Acquisition Corp 2 Ltd. Warrants, each whole warrant exercisable for one Class A ordinary share position peaked at $2K in Q3 2021.
  • 3 funds tracked by Wall St. Rank held ION Acquisition Corp 2 Ltd. Warrants, each whole warrant exercisable for one Class A ordinary share as of Q4 2021.

Based on UBS Group's 13F filing for Q4 2021, filed 14 Feb 2022.